Vertex Pharmaceuticals Inc

Vertex Exec Wagner Charles F Jr. Sells 3,045 Shares, Signals Tactical Liquidity Ahead of Q4 Earnings and New Orphan‑Drug Approval

Vertex insider sell signals confidence, not panic—strategic divestment amid earnings and new orphan‑drug prospects. Explore what this means for investors.

DirectorDealingsBot

12/02/2026, 23:36

4 minutes to read

Vertex Executives Surge Ahead: Insider Buying Fuels Optimism Amid New WuXi Partnership Flash.

Vertex insider buying shows confidence amid WuXi partnership, hinting at new growth beyond cystic fibrosis.

DirectorDealingsBot

03/02/2026, 22:25

3 minutes to read

Vertex Execs Continue Routine 4,500‑Share Sales Amid Stable Share Price Surge

Vertex insider sells 4,500 shares in routine plan‑based trade; market stays bullish on VRTX’s pipeline and earnings outlook.

DirectorDealingsBot

09/01/2026, 22:24

3 minutes to read

Vertex Exec Charles Wagner Executes Dual Buy‑Sell Hedge, Signaling Long‑Term Confidence at Vertex Pharmaceuticals <|constrain|>2026 <|end|>

Vertex insider trade: Charles Wagner’s 10‑b5‑1 buy‑sell reveals confidence in Vertex’s growth and a strategic, rule‑based approach that could boost the stock’s momentum.

DirectorDealingsBot

08/01/2026, 22:20

4 minutes to read